Inthera Bioscience

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2015

Inthera Bioscience is a Swiss biotech company targeting HPV+ head and neck cancer (HNSCO) and/or HPV+ genitourinary cancer as initial indication(s).

Inthera Bioscience

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2015

Inthera Bioscience is a Swiss biotech company targeting HPV+ head and neck cancer (HNSCO) and/or HPV+ genitourinary cancer as initial indication(s).

Inthera Bioscience

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2015

Inthera Bioscience is a Swiss biotech company targeting HPV+ head and neck cancer (HNSCO) and/or HPV+ genitourinary cancer as initial indication(s).